Literature DB >> 1137510

Cerebral vasospasm and ruptured intracranial aneurysm.

C H Millikan.   

Abstract

The literature concerning cerebral vasospasm associated with subarachnoid hemorrhage (SAH) due to ruptured intracranial aneurysm contains no definitive study of patients to determine whether there is (1) any clinical picture consistently present coincident with known cerebral vasospasm, (2) any relationship between mortality and known vasospasm, and (3) any relationship between serious brain damage (morbidity) and known vasospasm. To answer these important questions, experience with 198 consecutive acute SAH patients (every patient had a cerebral angiogram demonstrating one or more intracranial aneurysms) was studied. The experience with these 198 consecutive patients led to the conclusions that (1) there is no clinical picture consistently present coincident with known cerebral vasospasm; (2) cerebral vasospasm has no effect on the mortality from SAH due to ruptured aneurysm; and (3) there is no relationship between the frequency and severity of the complications from surgical or conservative treatment and the presence or absence of vasospasm.

Entities:  

Mesh:

Year:  1975        PMID: 1137510     DOI: 10.1001/archneur.1975.00490490037003

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  23 in total

1.  Delayed effects of subarachnoid haemorrhage on cerebral metabolism and the cerebrovascular response to hypercapnia in the primate.

Authors:  D P Boisvert; J D Pickard; D I Graham; W Fitch
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-10       Impact factor: 10.154

2.  Arterial spasm and recovery from subarachnoid haemorrhage.

Authors:  J T Richardson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154

3.  [Arachidonic acid metabolism following aneurysm rupture].

Authors:  V Seifert; D Stolke; V Kaever; H Dietz
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

4.  Refractory caffeine and ergot-induced cervico-cerebral vasospasm and stroke treated with combined medical and endovascular approach.

Authors:  Megan Miller; Avinash B Kumar; Charles R Callison
Journal:  Neuroradiology       Date:  2011-04-06       Impact factor: 2.804

5.  Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials.

Authors:  R Loch Macdonald; Randall T Higashida; Emanuela Keller; Stephan A Mayer; Andy Molyneux; Andreas Raabe; Peter Vajkoczy; Isabel Wanke; Aline Frey; Angelina Marr; Sébastien Roux; Neal F Kassell
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

6.  Delayed cerebral ischaemia: the pathological substrate.

Authors:  G Neil-Dwyer; D A Lang; B Doshi; C J Gerber; P W Smith
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  2-Chloro-2' deoxyadenosine prevents angiopathic changes in cerebral arteries in experimental SAH in rabbits.

Authors:  M Ryba; P Grieb; M Walski; J Sawicki; M Pastuszko
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

8.  The relationship between delayed infarcts and angiographic vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Robert J Brown; Abhay Kumar; Rajat Dhar; Tomoko R Sampson; Michael N Diringer
Journal:  Neurosurgery       Date:  2013-05       Impact factor: 4.654

9.  Controversy: does prevention of vasospasm in subarachnoid hemorrhage improve clinical outcome?

Authors:  Michael N Diringer
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

Review 10.  "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.

Authors:  Kendall H Lee; Timothy Lukovits; Jonathan A Friedman
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.